{
    "clinical_study": {
        "@rank": "111091", 
        "arm_group": [
            {
                "arm_group_label": "Donepezil HCL", 
                "arm_group_type": "Active Comparator", 
                "description": "Participants will receive 5mg of donepezil HCL for 4 weeks and then 10mg of donepezil HCL for 20 weeks."
            }, 
            {
                "arm_group_label": "Placebo", 
                "arm_group_type": "Placebo Comparator", 
                "description": "Participants will receive placebo for 24 weeks."
            }, 
            {
                "arm_group_label": "Control Group", 
                "arm_group_type": "No Intervention", 
                "description": "Participants without a family history of AD will undergo the study evaluations but will not receive any study drug"
            }
        ], 
        "brief_summary": {
            "textblock": "This 24-week study will examine the sensitivity of functional MRI to detect brain changes\n      caused by donepezil HCL (a cholinesterase inhibitor) in healthy older adults at genetic risk\n      for Alzheimer's Disease. Participants with a family history of Alzheimer's Disease will be\n      eligible for this study. Participants without a family history of AD will also be enrolled\n      to serve as a control group."
        }, 
        "brief_title": "Effects of Donepezil HCL on Task-Activated fMRI Brain Activation in Healthy Older Adults at Genetic Risk for Alzheimer's Disease", 
        "condition": "Genetic Risk for Alzheimer's Disease", 
        "condition_browse": {
            "mesh_term": "Alzheimer Disease"
        }, 
        "eligibility": {
            "criteria": {
                "textblock": "Inclusion Criteria:\n\n          -  Normal general cognitive function\n\n          -  High Risk Group Only: Family history (1st degree relative) of AD\n\n          -  Low Risk Group Only: No family history (1st or 2nd degree relative) of AD\n\n          -  Visual and auditory acuity adequate for neuropsychological testing\n\n        Exclusion Criteria:\n\n          -  Current or past history of\n\n          -  neurological illnesses/conditions\n\n          -  head trauma with significant loss of consciousness\n\n          -  medical illnesses/conditions that may affect brain function\n\n          -  severe psychiatric disorder\n\n          -  substance abuse\n\n          -  unstable or severe cardiovascular disease or asthmatic condition\n\n          -  history of stroke or transient ischemic attack"
            }, 
            "gender": "Both", 
            "healthy_volunteers": "Accepts Healthy Volunteers", 
            "maximum_age": "75 Years", 
            "minimum_age": "60 Years"
        }, 
        "enrollment": {
            "#text": "90", 
            "@type": "Anticipated"
        }, 
        "firstreceived_date": "March 7, 2014", 
        "has_expanded_access": "No", 
        "id_info": {
            "nct_id": "NCT02087865", 
            "org_study_id": "NIH AG022304"
        }, 
        "intervention": [
            {
                "arm_group_label": "Donepezil HCL", 
                "intervention_name": "donepezil HCL", 
                "intervention_type": "Drug"
            }, 
            {
                "arm_group_label": "Placebo", 
                "intervention_name": "Placebo", 
                "intervention_type": "Drug"
            }
        ], 
        "intervention_browse": {
            "mesh_term": "Donepezil"
        }, 
        "is_fda_regulated": "Yes", 
        "is_section_801": "Yes", 
        "lastchanged_date": "May 12, 2014", 
        "location": {
            "facility": {
                "address": {
                    "city": "Cleveland", 
                    "country": "United States", 
                    "state": "Ohio", 
                    "zip": "44195"
                }, 
                "name": "Cleveland Clinic Center for Brain Health"
            }, 
            "investigator": {
                "last_name": "Stephen M Rao, PhD", 
                "role": "Principal Investigator"
            }, 
            "status": "Recruiting"
        }, 
        "location_countries": {
            "country": "United States"
        }, 
        "number_of_arms": "3", 
        "official_title": "Effects of Donepezil HCL on Task-Activated fMRI Brain Activation in Healthy Older Adults at Genetic Risk for Alzheimer's Disease", 
        "overall_contact": {
            "email": "mouranl@ccf.org", 
            "last_name": "Lyla Mourany, M.S.", 
            "phone": "216-636-5522"
        }, 
        "overall_official": {
            "affiliation": "The Cleveland Clinic", 
            "last_name": "Stephen M Rao, Ph.D.", 
            "role": "Principal Investigator"
        }, 
        "overall_status": "Recruiting", 
        "oversight_info": {
            "authority": "United States: Food and Drug Administration", 
            "has_dmc": "No"
        }, 
        "phase": "Phase 4", 
        "primary_completion_date": {
            "#text": "April 2015", 
            "@type": "Anticipated"
        }, 
        "primary_outcome": {
            "description": "Changes from baseline to 6 month follow-up fMRI", 
            "measure": "Change in BOLD response during functional magnetic resonance imaging", 
            "safety_issue": "No", 
            "time_frame": "6 months"
        }, 
        "required_header": {
            "download_date": "ClinicalTrials.gov processed this data on June 04, 2014", 
            "link_text": "Link to the current ClinicalTrials.gov record.", 
            "url": "http://clinicaltrials.gov/show/NCT02087865"
        }, 
        "responsible_party": {
            "responsible_party_type": "Sponsor"
        }, 
        "secondary_outcome": {
            "description": "Changes in neuropsychological testing scores from baseline to 6 month follow-up visit", 
            "measure": "Neuropsychological testing scores", 
            "safety_issue": "No", 
            "time_frame": "6 months"
        }, 
        "source": "The Cleveland Clinic", 
        "sponsors": {
            "collaborator": {
                "agency": "National Institute on Aging (NIA)", 
                "agency_class": "NIH"
            }, 
            "lead_sponsor": {
                "agency": "The Cleveland Clinic", 
                "agency_class": "Other"
            }
        }, 
        "start_date": "May 2014", 
        "study_design": "Allocation: Randomized, Intervention Model: Parallel Assignment, Masking: Double Blind (Subject, Caregiver, Outcomes Assessor)", 
        "study_type": "Interventional", 
        "verification_date": "May 2014"
    }
}